Publication: 176

Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials
      QxMD      Google Scholar   
Citation:
Ann Oncol vol 21 (2) 312-318
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA032291, CA33601, U10 CA077658, CA32291, CA41287, U10 CA031946, CA77651, U10 CA033601, CA60138, 5P50CA9038, U10 CA077440, CA77440, U10 CA041287, U10 CA047559, U10 CA077651, CA04326, CA47559, CA31946  
Corr. Author:
 
Authors:
                 
Networks:
 
Study
CALGB-99813
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
carboplatin, estramustine, prostate cancer, taxanes